These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 34705473)

  • 1. Chemical Enhancement Effect of Icotinib-Au Complex Studied by Combined Density Functional Theory and Surface-Enhanced Raman Scattering.
    Lian S; Gao X; Song C; Li H; Lin J
    Langmuir; 2021 Nov; 37(44):12907-12918. PubMed ID: 34705473
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The chemical adsorption effect of surface enhanced Raman spectroscopy of nitrobenzene and aniline using the density functional theory.
    Wang Q; Lian S; Guo C; Gao X; Dou Y; Song C; Lin J
    Spectrochim Acta A Mol Biomol Spectrosc; 2022 Oct; 279():121428. PubMed ID: 35660148
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The characteristics of Raman spectroscopy of isomer CBD- and THC-Au nanoparticles using the density functional theory.
    Lian S; Gao X; Song C; Li H; Chen A; Lin J
    Spectrochim Acta A Mol Biomol Spectrosc; 2022 Mar; 268():120682. PubMed ID: 34906842
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Colloidal gold nanoparticle conjugates of gefitinib.
    Lam AT; Yoon J; Ganbold EO; Singh DK; Kim D; Cho KH; Lee SY; Choo J; Lee K; Joo SW
    Colloids Surf B Biointerfaces; 2014 Nov; 123():61-7. PubMed ID: 25216919
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Density Functional Theory and Raman Spectroscopy Studies of Adsorption Sites of Au Nanoparticles with Alectinib.
    Guo C; Gao X; Wang Q; Song C; Yu H; Wang Q; Dou Y; Lin J
    Langmuir; 2023 Dec; 39(51):19048-19055. PubMed ID: 38096548
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Investigation on the protein-binding properties of icotinib by spectroscopic and molecular modeling method.
    Zhang HX; Xiong HX; Li LW
    Spectrochim Acta A Mol Biomol Spectrosc; 2016 May; 161():88-94. PubMed ID: 26963729
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Au@Phenyacetylene organogold clusters: direct spectroscopic evidence of gold-carbon covalent band.
    Zhang H; Yin P; You T; Sun T; Lang X; Tan E; Liang X; Guo L
    Spectrochim Acta A Mol Biomol Spectrosc; 2015 Jan; 134():96-100. PubMed ID: 25004901
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of Au
    Guo C; Song C; Wang Q; Dou Y; Gao X; Chen A; Lin J
    Langmuir; 2023 Oct; 39(39):13968-13975. PubMed ID: 37734007
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adsorption and desorption of tyrosine kinase inhibitor erlotinib on gold nanoparticles.
    Lam AT; Yoon J; Ganbold EO; Singh DK; Kim D; Cho KH; Son SJ; Choo J; Lee SY; Kim S; Joo SW
    J Colloid Interface Sci; 2014 Jul; 425():96-101. PubMed ID: 24776669
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-tumor activity of high-dose EGFR tyrosine kinase inhibitor and sequential docetaxel in wild type EGFR non-small cell lung cancer cell nude mouse xenografts.
    Tang N; Zhang Q; Fang S; Han X; Wang Z
    Oncotarget; 2017 Feb; 8(6):9134-9143. PubMed ID: 27852073
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Density functional theory study on Herzberg-Teller contribution in Raman scattering from 4-aminothiophenol-metal complex and metal-4-aminothiophenol-metal junction.
    Liu S; Zhao X; Li Y; Zhao X; Chen M
    J Chem Phys; 2009 Jun; 130(23):234509. PubMed ID: 19548741
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Icotinib: activity and clinical application in Chinese patients with lung cancer.
    Guan YS; He Q; Li M
    Expert Opin Pharmacother; 2014 Apr; 15(5):717-28. PubMed ID: 24588695
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potential mechanism of primary resistance to icotinib in patients with advanced non-small cell lung cancer harboring uncommon mutant epidermal growth factor receptor: A multi-center study.
    Lei L; Wang WX; Zhu YC; Li JL; Fang Y; Wang H; Zhuang W; Zhang YB; Wang LP; Fang MY; Xu CW; Wang XJ; Lv TF; Song Y
    Cancer Sci; 2020 Feb; 111(2):679-686. PubMed ID: 31828849
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Icotinib versus whole-brain irradiation in patients with EGFR-mutant non-small-cell lung cancer and multiple brain metastases (BRAIN): a multicentre, phase 3, open-label, parallel, randomised controlled trial.
    Yang JJ; Zhou C; Huang Y; Feng J; Lu S; Song Y; Huang C; Wu G; Zhang L; Cheng Y; Hu C; Chen G; Zhang L; Liu X; Yan HH; Tan FL; Zhong W; Wu YL
    Lancet Respir Med; 2017 Sep; 5(9):707-716. PubMed ID: 28734822
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anticancer activity of indapamide adsorbed on gold nanoparticles: DFT, in-silico, and in-vitro analysis.
    Shyni V; Leenaraj DR; Ittyachan R; Joseph L; Sajan D
    J Mol Recognit; 2021 Oct; 34(10):e2920. PubMed ID: 34114274
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Phase I Study of the Safety and Pharmacokinetics of Higher-Dose Icotinib in Patients With Advanced Non-Small Cell Lung Cancer.
    Liu J; Wu L; Wu G; Hu X; Zhou H; Chen J; Zhu M; Xu W; Tan F; Ding L; Wang Y; Shentu J
    Oncologist; 2016 Nov; 21(11):1294-1295d. PubMed ID: 27789778
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of whole brain radiation therapy on CSF penetration ability of Icotinib in EGFR-mutated non-small cell lung cancer patients with brain metastases: Results of phase I dose-escalation study.
    Zhou L; He J; Xiong W; Liu Y; Xiang J; Yu Q; Liang M; Zhou X; Ding Z; Huang M; Ren L; Zhu J; Li L; Hou M; Ding L; Tan F; Lu Y
    Lung Cancer; 2016 Jun; 96():93-100. PubMed ID: 27133757
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcomes of concurrent versus sequential icotinib therapy and chemotherapy in advanced non-small cell lung cancer with sensitive EGFR mutations.
    Zhang Y; Wang J; Yu Z; Ge H; Zhang LW; Feng LX
    Clin Transl Sci; 2021 May; 14(3):890-897. PubMed ID: 33382908
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Icotinib versus gefitinib in previously treated advanced non-small-cell lung cancer (ICOGEN): a randomised, double-blind phase 3 non-inferiority trial.
    Shi Y; Zhang L; Liu X; Zhou C; Zhang L; Zhang S; Wang D; Li Q; Qin S; Hu C; Zhang Y; Chen J; Cheng Y; Feng J; Zhang H; Song Y; Wu YL; Xu N; Zhou J; Luo R; Bai C; Jin Y; Liu W; Wei Z; Tan F; Wang Y; Ding L; Dai H; Jiao S; Wang J; Liang L; Zhang W; Sun Y
    Lancet Oncol; 2013 Sep; 14(10):953-61. PubMed ID: 23948351
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of icotinib on advanced non-small cell lung cancer with different EGFR phenotypes.
    Pan H; Liu R; Li S; Fang H; Wang Z; Huang S; Zhou J
    Cell Biochem Biophys; 2014 Sep; 70(1):553-8. PubMed ID: 24777808
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.